J.-M. Boiron

1.1k total citations
34 papers, 711 citations indexed

About

J.-M. Boiron is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, J.-M. Boiron has authored 34 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in J.-M. Boiron's work include Hematopoietic Stem Cell Transplantation (15 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Acute Myeloid Leukemia Research (6 papers). J.-M. Boiron is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Acute Myeloid Leukemia Research (6 papers). J.-M. Boiron collaborates with scholars based in France, United Kingdom and Switzerland. J.-M. Boiron's co-authors include Josy Reiffers, Gérald Marit, C. Fabères, Pascale Cony‐Makhoul, C Bilhou-Nabéra, Arnaud Pigneux, F.-X. Mahon, Gilles Hilbert, Didier Gruson and Cécile Bébéar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

J.-M. Boiron

33 papers receiving 677 citations

Peers

J.-M. Boiron
Anna Paola Iori Italy
Helen Enright Ireland
W.Y. Au China
Photis Beris Switzerland
R Goudsmit Netherlands
Takakazu Higuchi Japan
Y. Ravindranath United States
Frauke Bergmann Germany
P. D. Roberts United Kingdom
Kaan Kavaklı Türkiye
Anna Paola Iori Italy
J.-M. Boiron
Citations per year, relative to J.-M. Boiron J.-M. Boiron (= 1×) peers Anna Paola Iori

Countries citing papers authored by J.-M. Boiron

Since Specialization
Citations

This map shows the geographic impact of J.-M. Boiron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-M. Boiron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-M. Boiron more than expected).

Fields of papers citing papers by J.-M. Boiron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-M. Boiron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-M. Boiron. The network helps show where J.-M. Boiron may publish in the future.

Co-authorship network of co-authors of J.-M. Boiron

This figure shows the co-authorship network connecting the top 25 collaborators of J.-M. Boiron. A scholar is included among the top collaborators of J.-M. Boiron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-M. Boiron. J.-M. Boiron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilleron, V., et al.. (2010). Caractéristiques des patients transfusés au CHU de Bordeaux : étude descriptive à l’aide des données du PMSI et du système d’hémovigilance. Transfusion Clinique et Biologique. 17(4). 223–231. 1 indexed citations
2.
3.
Ivanović, Zoran & J.-M. Boiron. (2009). Expansion ex vivo des cellules hematopoiétiques : concept et utilité clinique. Transfusion Clinique et Biologique. 16(5-6). 489–500. 12 indexed citations
4.
Dhédin, Nathalie, Hervé Dombret, Xavier Thomas, et al.. (2005). Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials. Leukemia. 20(2). 336–344. 28 indexed citations
5.
Fricain, Jean‐Christophe, et al.. (2005). Les manifestations buccales de la réaction du greffon contre l’hôte. Annales de Dermatologie et de Vénéréologie. 132(12). 1017–1025. 9 indexed citations
6.
Valteau-Couanet, D, Catherine Faucher, A. Aupérin, et al.. (2005). Cost effectiveness of day 5 G-CSF (Lenograstim®) administration after PBSC transplantation: results of a SFGM-TC randomised trial. Bone Marrow Transplantation. 36(6). 547–552. 30 indexed citations
7.
Mohty, Mohamad, J.-M. Boiron, Anne‐Sophie Michallet, et al.. (2004). Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplantation. 34(1). 77–84. 57 indexed citations
8.
Mahon, F.-X., X. Delbrel, Pascale Cony‐Makhoul, et al.. (2002). Follow-Up of Complete Cytogenetic Remission in Patients With Chronic Myeloid Leukemia After Cessation of Interferon Alfa. Journal of Clinical Oncology. 20(1). 214–220. 52 indexed citations
9.
Jourdan, Éric, Josy Reiffers, Anne Marie Stoppa, et al.. (2001). Outcome of Adult Patients with Acute Myeloid Leukemia who Failed to Achieve Complete Remission after one Course of Induction Chemotherapy: A Report from the BGMT Study Group: For the BGMT. Leukemia & lymphoma. 42(1-2). 57–65. 10 indexed citations
10.
Accoceberry, Isabelle, François‐Xavier Weill, Philippe Agapé, et al.. (1999). Intérêt du dosage sérique de l'antigène galactomannane par méthode ELISA chez les patients présentant un risque d'aspergillose invasive dans un service d'hématologie. Journal de Mycologie Médicale. 12(3). 131–135. 2 indexed citations
11.
Boiron, J.-M., J Cahn, Giovanna Meloni, et al.. (1999). Chronic myeloid leukemia in first chronic phase not responding to α-interferon: outcome and prognostic factors after autologous transplantation. Bone Marrow Transplantation. 24(3). 259–264. 8 indexed citations
12.
Gruson, Didier, Gilles Hilbert, L. Portel, et al.. (1999). Severe respiratory failure requiring ICU admission in bone marrow transplant recipients. European Respiratory Journal. 13(4). 883–883. 94 indexed citations
13.
Cotteret, Sophie, Françis Belloc, J.-M. Boiron, et al.. (1998). Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogeneic bone marrow transplantation. Cytometry. 34(5). 216–222. 8 indexed citations
14.
Boiron, J.-M., et al.. (1997). Expansion of Blood CD34+ Cells: Committed Precursor Expansion Does Not Affect Immature Hematopoietic Progenitors. Journal of Hematotherapy. 6(2). 151–158. 18 indexed citations
15.
Boiron, J.-M., et al.. (1997). Plasma cytokines in graft vs host disease and complications following bone marrow transplantation. PubMed. 39(1). 27–32. 28 indexed citations
16.
Marit, Gérald, C. Fabères, J L Pico, et al.. (1996). Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma.. Journal of Clinical Oncology. 14(4). 1306–1313. 26 indexed citations
17.
Moreau‐Gaudry, François, Cécile Ged, Cécile Barbot, et al.. (1995). Correction of the Enzyme Defect in Cultured Congenital Erythropoietic Porphyria Disease Cells by Retrovirus-Mediated Gene Transfer. Human Gene Therapy. 6(1). 13–20. 22 indexed citations
18.
Boiron, J.-M., et al.. (1994). Cytokine-Mediated Expansion of 5-FU Resistant Peripheral Blood Stem Cells and Bone Marrow: Self-Renewal and Commitment Capacity*. Journal of Hematotherapy. 3(2). 135–139. 3 indexed citations
19.
Cony-Makhoul, P, et al.. (1994). Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation. Blood Reviews. 8(4). 234–240. 5 indexed citations
20.
Duperray, Christophe, J.-M. Boiron, Claude Boucheix, et al.. (1990). The CD24 antigen discriminates between pre-B and B cells in human bone marrow.. The Journal of Immunology. 145(11). 3678–3683. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Paola Iori Breakdown of academic impact, for papers by Helen Enright Breakdown of academic impact, for papers by W.Y. Au Breakdown of academic impact, for papers by Photis Beris Breakdown of academic impact, for papers by R Goudsmit Breakdown of academic impact, for papers by Takakazu Higuchi Breakdown of academic impact, for papers by Y. Ravindranath Breakdown of academic impact, for papers by Frauke Bergmann Breakdown of academic impact, for papers by P. D. Roberts Breakdown of academic impact, for papers by Kaan Kavaklı
Rankless by CCL
2026